Not Yet Recruiting
A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
NCT07205796
- Conditions
- Chickenpox, DNA Virus Infections, Herpes Zoster, +8 more
- Locations
-
Not specified